journal
Journals Expert Review of Cardiovascula...

Expert Review of Cardiovascular Therapy

https://read.qxmd.com/read/36881733/vericiguat-for-the-treatment-of-heart-failure-with-reduced-ejection-fraction
#1
JOURNAL ARTICLE
Ahmed K Siddiqi, Stephen J Greene, Marat Fudim, Robert J Mentz, Javed Butler, Muhammad Shahzeb Khan
INTRODUCTION: Despite significant therapeutic advancements in heart failure with reduced ejection fraction (HFrEF), the residual risk of all-cause mortality and hospitalizations remains high among patients with HFrEF. Vericiguat is a novel oral soluble guanylate cyclase (sGC) stimulator which was approved by the US Food and Drug administration (FDA) in January 2021 for use in patients with symptomatic chronic HF and an ejection fraction less than 45% following a hospitalization for HF or the need for outpatient intravenous diuretics...
March 7, 2023: Expert Review of Cardiovascular Therapy
https://read.qxmd.com/read/36877129/short-term-risk-of-periprocedural-stroke-relative-to-radial-vs-femoral-access-systematic-review-meta-analysis-study-sequential-analysis-and-meta-regression-of-2-188-047-real-world-cardiac-catheterizations
#2
JOURNAL ARTICLE
Jan Tužil, Jan Matějka, Mamas A Mamas, Tomáš Doležal
OBJECTIVES: To verify whether transradial (TRA) compared to transfemoral (TFA) cardiac catheterization reduces the risk of periprocedural stroke (PS). METHODS: We reviewed (CRD42021277918) published real-world cohorts reporting the incidence of PS within 3 days following diagnostic or interventional catheterization. Meta-analyses and meta-regressions of odds ratios (OR) performed using the DerSimonian and Laird method were checked for publication bias (Egger test) and adjusted for false-positive results (study sequential analysis SSA)...
March 7, 2023: Expert Review of Cardiovascular Therapy
https://read.qxmd.com/read/36877090/heart-failure-and-excess-mortality-after-aortic-valve-replacement-in-aortic-stenosis
#3
JOURNAL ARTICLE
Nikoo Aziminia, Christian Nitsche, Rok Mravljak, Jonathan Bennett, George D Thornton, Thomas A Treibel
INTRODUCTION: In aortic stenosis (AS), the heart transitions from adaptive compensation to an AS cardiomyopathy and eventually leads to decompensation with heart failure. Better understanding of the underpinning pathophysiological mechanisms is required in order to inform strategies to prevent decompensation. AREAS COVERED: In this review, we therefore aim to appraise the current pathophysiological understanding of adaptive and maladaptive processes in AS, appraise potential avenues of adjunctive therapy before or after AVR and highlight areas of further research in the management of heart failure post AVR...
March 6, 2023: Expert Review of Cardiovascular Therapy
https://read.qxmd.com/read/36866613/heightened-risks-of-cardiovascular-disease-in-south-asian-populations-causes-and-consequences
#4
JOURNAL ARTICLE
Maria Stefil, Jack Bell, Peter Calvert, Gregory Yh Lip
INTRODUCTION: : South Asian individuals comprise almost a quarter of the world's population and have an excess risk of atherosclerotic cardiovascular disease (ASCVD) compared to other ethnicities. In part this can be explained by the higher prevalence, earlier onset, and suboptimal control of traditional cardiovascular risk factors, such as insulin resistance, metabolic syndrome, and dyslipidaemia. However, there remains a significant residual excess risk associated with South Asian ethnicity after controlling for traditional risk factors...
March 3, 2023: Expert Review of Cardiovascular Therapy
https://read.qxmd.com/read/36856339/covid-19-and-its-long-term-impact-on-the-cardiovascular-system
#5
JOURNAL ARTICLE
Bejoy Philip, Prerona Mukherjee, Yuti Khare, Pranav Ramesh, Sara Zaidi, Haytham Sabry, Amer Harky
INTRODUCTION: The SARS-CoV-2 virus caused a pandemic which affected healthcare delivery globally. Despite the presentation of COVID-19 infection being frequently dominated by respiratory symptoms; it is now notorious to also have potentially serious cardiovascular sequelae. This article explores current available data to provide a comprehensive overview of the pathophysiology, cardiovascular risk factors and implications of COVID-19. AREAS COVERED: The inherent structure of SARS-CoV-2, and its interaction with both ACE-2 and non-ACE-2 mediated pathways have been implicated in the development of cardiovascular manifestations, progressively resulting in acute respiratory distress syndrome, multiorgan failure, cytokine release syndrome and subsequent myocardial damage...
March 1, 2023: Expert Review of Cardiovascular Therapy
https://read.qxmd.com/read/36852632/robotic-magnetic-guided-catheter-ablation-in-patients-with-congenital-heart-disease-a-systematic-review-and-pooled-analysis
#6
JOURNAL ARTICLE
Christophe Vô, Stefano Bartoletti, Karim Benali, Cecilia M Gonzalez, Blandine Mondésert, Marie-Hélène Gagnon, Katia Dyrda, Anne Fourier, Paul Khairy
BACKGROUND: Robotic magnetic navigation (RMN) has emerged as a potential solution to overcome challenges associated with catheter ablation of arrhythmias in patients with congenital heart disease (CHD). OBJECTIVES: To assess safety and efficacy of RMN-guided catheter ablation in patients with CHD. DESIGN AND METHODS: A systematic review and pooled analysis was conducted on patients with CHD who underwent RMN-guided catheter ablation. Random-effects models were used to generate pooled estimates with the inverse variance method used for weighting studies...
February 28, 2023: Expert Review of Cardiovascular Therapy
https://read.qxmd.com/read/36847583/opportunities-and-drawbacks-of-the-subcutaneous-defibrillator-across-different-clinical-settings
#7
JOURNAL ARTICLE
Vincenzo Russo, Michele Ciabatti, Michele Brunacci, Gregory Dendramis, Vincenzo Santobuono, Gianfranco Tola, Giuseppe Picciolo, Lucciola Maria Teresa, Antonello D'Andrea, Martina Nesti
INTRODUCTION: The subcutaneous implantable cardioverter-defibrillator (S-ICD) is an established therapy for the prevention of sudden cardiac death (SCD) and an alternative to a transvenous implantable cardioverter-defibrillator system in selected patients. Beyond randomized clinical trials, many observational studies described the clinical performance of S-ICD across different subgroups of patients. AREAS COVERED: Our review aimed to describe the opportunities and drawbacks of the S-ICD, focusing on their use in special populations and across different clinical settings...
February 27, 2023: Expert Review of Cardiovascular Therapy
https://read.qxmd.com/read/36846957/decision-making-in-anomalous-aortic-origin-of-a-coronary-artery
#8
JOURNAL ARTICLE
Hitesh Agrawal, Alexandra Lamari-Fisher, Keren Hasbani, Stephanie Philip, Charles D Fraser, Carlos M Mery
INTRODUCTION: There are many uncertainties surrounding anomalous aortic origin of a coronary artery (AAOCA) including the pathophysiology of sudden cardiac death, how to best risk stratify patients, how to best evaluate patients, who would benefit from exercise restriction, who should undergo surgical intervention and which operation to perform. AREAS COVERED: The goal of this review is to provide a comprehensive, but succinct overview of AAOCA to help clinicians with the difficult task of navigating optimal evaluation and treatment of an individual patient with AAOCA...
February 27, 2023: Expert Review of Cardiovascular Therapy
https://read.qxmd.com/read/36825458/safety-and-efficacy-of-intracoronary-thrombolytic-agents-during-primary-percutaneous-coronary-intervention-for-stemi
#9
JOURNAL ARTICLE
Natasha Kulick, Kevin Friede, George A Stouffer
INTRODUCTION: Large thrombus burden in patients with ST elevation myocardial infarction (STEMI) is associated with higher rates of distal embolization, no-reflow phenomenon, abrupt closure, stent thrombosis, major adverse cardiovascular events (MACE), and mortality. Intracoronary (IC) thrombolytic agents are theoretically attractive as an adjunct to primary percutaneous coronary intervention (PPCI) as they activate endogenous fibrinolysis which results in degradation of the cross-linked fibrin matrix in coronary thrombus...
February 24, 2023: Expert Review of Cardiovascular Therapy
https://read.qxmd.com/read/36821251/angiotensin-converting-enzyme-inhibitors-and-angiotensin-ii-receptor-blockers-and-outcomes-in-hospitalized-patients-with-covid-19-an-updated-systematic-review-and-meta-analysis-of-randomized-clinical-trials
#10
JOURNAL ARTICLE
Joseph Alexander Paguio, Bruce Adrian Casipit, Tara A John, Aniruddh Balu, Kevin Bryan Lo
BACKGROUND: : Our previous review of observational data demonstrated no significant difference in risk of mortality or disease progression among patients with COVID-19. With the recent availability of findings from randomized controlled trials (RCTs), we provide an updated review of RCTs which explored the outcomes among hospitalized patients with COVID-19 treated with Angiotensin Converting Enzyme inhibitor (ACEis)/Angiotensin Receptor Blockers (ARBs) versus control. RESEARCH DESIGN AND METHODS: This systematic review and meta-analysis covers RCTs exploring mortality, intensive care unit admission, and mechanical ventilation outcomes among hospitalized COVID-19 patients treated with ACEi/ARBs versus control...
February 23, 2023: Expert Review of Cardiovascular Therapy
https://read.qxmd.com/read/36745028/social-determinants-of-pacemaker-reuse-among-patients-and-family-members-in-pakistan
#11
JOURNAL ARTICLE
Bilal Mustafa, Hamza Butt, Muhammad Shahbaz Khan, Sarim Rashid, Tayyiba Ahmed Noor, Shafiq Alam, Waheed Ashraf, Jahanzeb Malik
OBJECTIVES: This survey aimed to quantify the opinions of CIED reuse among patients and family members in Pakistan and to identify the social determinants which may predict these views. METHODS: A questionnaire formulating attitudes toward PPM reuse was administered to patients and family members at cardiology institutes in Pakistan from 1st July 2022 to 30th September 2022. The eligibility criteria (age > 18 years; inline for PPM placement) were taken into account and incomplete responses were excluded from the final analysis...
February 6, 2023: Expert Review of Cardiovascular Therapy
https://read.qxmd.com/read/36744389/the-role-of-serial-cardiac-biomarkers-in-prognostication-and-risk-prediction-of-chronic-heart-failure-additional-scientific-insights-with-hemodynamic-feedback
#12
JOURNAL ARTICLE
Youssra Allach, J J Brugts
INTRODUCTION: Heart failure (HF) is considered as a chronic long-term and lethal disease, and will continue to be a major public health problem. Studying (circulating) biomarkers is a promising field of research and could be the first step towards HF tailored prognostic strategies as well as understanding the response to HF drugs in CHF patients. AREAS COVERED: In literature, there has been considerable research on elevated biomarker levels that are related to a poor prognosis for HF...
February 6, 2023: Expert Review of Cardiovascular Therapy
https://read.qxmd.com/read/36716079/the-pathophysiology-and-management-of-vascular-calcification-in-chronic-kidney-disease-patients
#13
JOURNAL ARTICLE
Mehmet Kanbay, Sidar Copur, Cem Tanriover, Furkan Yavuz, Andrea Galassi, Paola Ciceri, Mario Cozzolino
INTRODUCTION: Vascular calcification (VC) which is the pathological mineral deposition in the vascular system, predominantly at the intimal and medial layer of the vessel wall, is an important comorbidity in patients with chronic kidney disease (CKD) leading to significant morbidity and mortality while necessitating appropriate treatment. Our review aims to provide an in-depth analysis of the current understanding of VC. AREAS COVERED: In this review, we first discuss the pathophysiology of VC in CKD patients, then we explain the methods to predict and assess VC...
January 30, 2023: Expert Review of Cardiovascular Therapy
https://read.qxmd.com/read/36706282/the-many-roles-of-urgent-catheter-interventions-from-myocardial-infarction-to-acute-stroke-and-pulmonary-embolism
#14
JOURNAL ARTICLE
Viktor Klancik, Viktor Kočka, Jakub Sulzenko, Petr Widimsky
INTRODUCTION: Cardiovascular diseases (CVDs) are the leading cause of cardiovascular mortality and a major contributor to disability worldwide. The prevalence of CVDs is continuously increasing, and from 1990 to 2019, it has doubled. Global cardiovascular mortality has increased from 12.1 million in 1990 to 18.6 million cases in 2019. UNLABELLED: The development of therapeutic options for these diseases is at the forefront of interest concerning the extensive socio-economic consequences...
January 27, 2023: Expert Review of Cardiovascular Therapy
https://read.qxmd.com/read/36706273/association-of-physical-activity-and-trajectories-of-physical-activity-with-cardiovascular-disease
#15
JOURNAL ARTICLE
Steven G Chrysant, George S Chrysant
INTRODUCTION: Prolonged sedentary life existence is associated with increased incidence of cardiovascular disease (CVD), coronary heart disease (CHD), obesity, type 2 diabetes mellitus (T2DM), hypertension, heart failure (HF), and all-cause mortality. On the contrary, regular exercise is known from antiquity to be associated with beneficial cardiovascular (CV) effects and decreased mortality. AREAS COVERED: The cardiovascular (CV) benefits of exercise have been confirmed by many studies, but the trajectories of the different modes of PA are not well recognized...
January 27, 2023: Expert Review of Cardiovascular Therapy
https://read.qxmd.com/read/36680789/atrial-fibrillation-ablation-as-first-line-therapy-for-patients-with-heart-failure-with-reduced-ejection-fraction-hfref-evaluating-the-impact-on-patient-survival
#16
JOURNAL ARTICLE
Hadi Younes, Charbel Noujaim, Mario Mekhael, Nour Chouman, Ala Assaf, Omar Kreidieh, Chanho Lim, Nassir Marrouche, Eoin Donnellan
INTRODUCTION: Atrial fibrillation and congestive heart failure share several pathophysiological mechanisms. As a result of their association, patients have worse outcomes than if either condition was present alone. AREAS COVERED: While multiple trials report no significant difference between the use of pharmacological rhythm control and the use of rate control in terms of mortality and morbidity in patients with HFrEF, there is evidence to suggest that catheter ablation is beneficial in this patient population...
January 21, 2023: Expert Review of Cardiovascular Therapy
https://read.qxmd.com/read/36537565/atrial-fibrillation-and-stroke
#17
JOURNAL ARTICLE
Sylvia E Choi, Dimitrios Sagris, Andrew Hill, Gregory Y H Lip, Azmil H Abdul-Rahim
INTRODUCTION: Stroke is one of the leading causes of mortality and morbidity globally. Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia. It is set to reach epidemic proportions. AF is associated with a five-fold increase in risk of stroke. Strokes caused by AF more often are fatal or result in severe disability. Even though the incidence of stroke has been significantly reduced by oral anticoagulation, AF is thought to account for a significant proportion of cryptogenic strokes where no etiology is identified...
January 8, 2023: Expert Review of Cardiovascular Therapy
https://read.qxmd.com/read/36597921/trends-and-outcomes-of-cardiogenic-shock-in-asian-populations-compared-with-non-asian-populations-in-the-us-nis-analysis-2002-2019
#18
JOURNAL ARTICLE
Harigopal Sandhyavenu, Waqas Ullah, Irisha Badu, Amro Taha, Aravind Reddy Polam, Tanveer Mir, Yevgeniy Brailovsky, Indranee N Rajapreyar, Saraschandra Vallabhajosyula, M Chadi Alraies
BACKGROUND: Current understanding of outcomes of cardiogenic shock (CS) in Asian populations is limited. We aim to study the clinical outcomes of CS in Asian population compared with non-Asians in the US. METHODS: The National Inpatient Sample (NIS) database was queried between 2002-2019 to identify hospitalizations with CS. Race was classified as Asians and non-Asians. The adjusted odds ratios (aOR) for in-hospital outcomes were calculated using multivariate logistic regression analysis...
January 4, 2023: Expert Review of Cardiovascular Therapy
https://read.qxmd.com/read/36543329/conventional-aortic-root-vs-valve-sparing-root-replacement-surgery-in-aortic-dilatation-syndromes-a-comparison-of-mortality-and-postoperative-complications
#19
JOURNAL ARTICLE
Hashrul N Rashid, Omar Chehab, Harriet Hurrell, Vitaly Androshchuk, Agata Sularz, Tiffany Patterson, Gianluca Lucchese, Simon Redwood
INTRODUCTION: Conventional aortic root and valve-sparing root replacement surgery are two current surgical treatments for aortic dilatation syndromes. This review article aims to review the current literature surrounding these two established techniques. AREAS COVERED: This review article will address the current indications for valve-sparing root replacement surgery, technical considerations in surgical planning and a comparison of clinical outcomes between these two surgical techniques...
December 28, 2022: Expert Review of Cardiovascular Therapy
https://read.qxmd.com/read/36534926/how-has-covid-19-impacted-the-care-of-patients-with-acute-coronary-syndromes
#20
EDITORIAL
Arturo Cesaro, Gianantonio De Michele, Felice Gragnano, Paolo Calabrò
No abstract text is available yet for this article.
December 26, 2022: Expert Review of Cardiovascular Therapy
journal
journal
40477
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.